Adele Fielding
Adele Kay Fielding | |
|---|---|
 | |
| Alma mater | University of London University College London |
| Scientific career | |
| Institutions | Mayo Clinic Royal Free Hospital University College London Hospitals NHS Foundation Trust University College London |
| Thesis | Targeting fusogenic retroviral glycoproteins by ligand display. (1999) |
Adele Kay Fielding is a British physician who is a Professor of Haematology at University College London. Fielding was President of the British Society for Haematology from 2020 until 2022.[1]
Early life and education
Fielding was a medical student at University College London.[2] She was a trainee in haematology (the medical specialty covering blood disorders including cancer) and general medicine in London. She moved to the Medical Research Council laboratory in Cambridge for her doctoral research, and completed her doctorate in 1999.[3][4]
Research and career
In 1999, Fielding was appointed assistant professor at the Mayo Clinic.[4] She returned to the United Kingdom in 2003, where she joined the Royal Free Hospital. She eventually moved to the University College London Hospitals NHS Foundation Trust, where she works in leukemia. Specifically, her research efforts look to improve the lives of people with acute lymphoblastic leukemia (ALL).[5] She is part of several clinical trials into ALL, which include studying the underlying mechanisms and searching for new treatments.[6] Fielding has developed an attenuated oncolytic measles virus that can be used as a treatment of ALL.[2]
Fielding was elected President of the British Society for Haematology in 2020 and was succeeded in 2022 by Josh Wright.[1][7]
Selected publications
- No label or title -- debug: Q40312849, Wikidata Q40312849
- No label or title -- debug: Q43889424, Wikidata Q43889424
- No label or title -- debug: Q34042800, Wikidata Q34042800
References
- ^ a b "A message from BSH President, Professor Adele Fielding - July 2020 | British Society for Haematology". b-s-h.org.uk. Retrieved 20 July 2021.
- ^ a b "Professor Adele Fielding : University College London Hospitals NHS Foundation Trust". www.uclh.nhs.uk. Retrieved 20 July 2021.
- ^ Fielding, Adele Kay (1999). Targeting fusogenic retroviral glycoproteins by ligand display (Thesis).
- ^ a b "Dr Adele Fielding – At the Limits". Retrieved 20 July 2021.
- ^ UCL (19 December 2017). "Biology of Adult Lymphoblastic Leukaemia and Oncolytic Virus Therapy Research Group". UCL Cancer Institute. Retrieved 20 July 2021.
- ^ "Professor Adele Fielding". Cancer Research UK. 6 February 2017. Retrieved 20 July 2021.
- ^ "Board of Trustees | British Society for Haematology". b-s-h.org.uk. Retrieved 20 July 2021.
External links
- Articles with short description
- Use dmy dates from April 2022
- Articles with hCards
- Twitter username not in Wikidata
- AC with 0 elements
- Living people
- 20th-century British medical doctors
- 21st-century British medical doctors
- British haematologists
- Alumni of the University of London
- Year of birth missing (living people)